Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mutation selection and tumour progression

T E Wheldon

    Medical Hypotheses
    |May 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Tumor progression may stem from increased cell mutability, leading to neutral mutations. These mutations can become lethal under specific conditions, explaining tumor thermosensitivity and supporting hyperthermia cancer treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Radiation carcinogenesis modelling for risk of treatment-related second tumours following radiotherapy.

    The British journal of radiology·2001
    Same author

    The effect of tissue-specific growth patterns of target stem cells on the spectrum of tumours resulting from multistage tumorigenesis.

    Journal of theoretical biology·2001
    Same author

    A gene therapy/targeted radiotherapy strategy for radiation cell kill by.

    The journal of gene medicine·2001
    Same author

    Radiobiological modelling of the treatment of leukaemia by total body irradiation.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2001
    Same author

    A gene therapy approach to enhance the targeted radiotherapy of neuroblastoma.

    Medical and pediatric oncology·2000
    Same author

    Radiation physics and genetic targeting: new directions for radiotherapy. The Douglas Lea Lecture 1999.

    Physics in medicine and biology·2000
    Same journal

    Calcitonin Gene-Related Peptide-Induced Central Sensitization: A Hypothesis for Long COVID Symptoms.

    Medical hypotheses·2026
    Same journal

    Subclinical mastitis during lactation: a modifiable risk factor for breast cancer?

    Medical hypotheses·2025
    Same journal

    The Role of Hemispheric Sensory Shifts: Impacts on Stretch Reflex and Motor Plasticity Post-Stroke.

    Medical hypotheses·2025
    Same journal

    Neuron-Targeted Exosome Therapy: A Novel Approach for Treating Cardiogenic Dementia via RyR2 Inhibition.

    Medical hypotheses·2025
    Same journal

    How the Somatosensory System Adapts to the Motor Change in Stroke: A Hemispheric Shift?

    Medical hypotheses·2024
    Same journal

    Unstable Plaque is a Treatable Cause of Cognitive Decline.

    Medical hypotheses·2024
    See all related articles

    Area of Science:

    • Oncology
    • Cancer Biology
    • Genetics

    Background:

    • Tumor progression is a complex process involving genetic alterations.
    • Cancer cells exhibit increased mutation rates compared to normal cells.
    • The role of neutral mutations in tumor evolution is not fully understood.

    Purpose of the Study:

    • To propose a mechanism linking tumor cell mutability to progression.
    • To explain the thermosensitivity of tumor cells.
    • To provide a rationale for hyperthermia in cancer therapy.

    Main Methods:

    • Theoretical proposal based on existing biological principles.
    • Analysis of mutation dynamics in tumor cells.
    • Correlation of mutation expression with environmental conditions.

    Related Experiment Videos

    Main Results:

    • Tumor progression may result from the accumulation of neutral mutations.
    • These neutral mutations can be expressed lethally under altered physiological conditions, such as high temperatures.
    • This mechanism provides a potential explanation for tumor thermosensitivity.

    Conclusions:

    • Increased tumor cell mutability drives tumor progression via neutral mutations.
    • Hyperthermia could exploit the conditional lethality of these mutations for cancer treatment.
    • This model offers a new perspective on cancer evolution and therapeutic strategies.